These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11321284)

  • 1. Development of reactive onchocercal skin lesions during a placebo-controlled trial with ivermectin among persons without lesions at baseline.
    Brieger WR; Kale OO; Ososanya OO
    Trop Doct; 2001 Apr; 31(2):96-8. PubMed ID: 11321284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial.
    Brieger WR; Awedoba AK; Eneanya CI; Hagan M; Ogbuagu KF; Okello DO; Ososanya OO; Ovuga EB; Noma M; Kale OO; Burnham GM; Remme JH
    Trop Med Int Health; 1998 Dec; 3(12):951-61. PubMed ID: 9892280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintaining compliance to ivermectin in communities in two West African countries.
    Whitworth JA; Alexander ND; Seed P; Thomas W; Abiose A; Jones BR
    Health Policy Plan; 1996 Sep; 11(3):299-307. PubMed ID: 10160375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stigma associated with onchocercal skin disease among those affected near the Ofiki and Oyan Rivers in western Nigeria.
    Brieger WR; Oshiname FO; Ososanya OO
    Soc Sci Med; 1998 Oct; 47(7):841-52. PubMed ID: 9722105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ivermectin treatment of onchocercal skin lesions: observations from a placebo-controlled, double-blind trial in Malawi.
    Burnham G
    Am J Trop Med Hyg; 1995 Mar; 52(3):270-6. PubMed ID: 7694970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The African Programme for Onchocerciasis Control: impact on onchocercal skin disease.
    Ozoh GA; Murdoch ME; Bissek AC; Hagan M; Ogbuagu K; Shamad M; Braide EI; Boussinesq M; Noma MM; Murdoch IE; Sékétéli A; Amazigo UV
    Trop Med Int Health; 2011 Jul; 16(7):875-83. PubMed ID: 21481109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multi-centre study of the effect of Mectizan treatment on onchocercal skin disease: clinical findings.
    Ogbuagu KF; Eneanya CI
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S139-45. PubMed ID: 9861280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in severe onchocercal skin disease after a single dose of ivermectin.
    Pacqué M; Elmets C; Dukuly ZD; Muñoz B; White AT; Taylor HR; Greene BM
    Am J Med; 1991 May; 90(5):590-4. PubMed ID: 2029016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and parasitological responses after up to 6.5 years of ivermectin treatment for onchocerciasis.
    Whitworth JA; Maude GH; Downham MD
    Trop Med Int Health; 1996 Dec; 1(6):786-93. PubMed ID: 8980590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of health education on community participation in rapid assessment of onchocerciasis prior to distribution of ivermectin.
    Shu EN; Nwadike KI; Onwujekwe EO; Ugwu OC; Okonkwo PO
    East Afr Med J; 1999 Jun; 76(6):320-3. PubMed ID: 10750518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Onchocerciasis].
    Enk CD; Gardlo K; Ruzicka T; BenEzra D
    Hautarzt; 2003 Jun; 54(6):513-7. PubMed ID: 12759735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ivermectin does not reduce the burden of itching in an onchocerciasis endemic community.
    Whitworth JA; Luty AJ; Maude GH; Morgan D; Downham MD; Taylor DW
    Trans R Soc Trop Med Hyg; 1992; 86(3):281-3. PubMed ID: 1412653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of 5 years of annual treatment with ivermectin (Mectizan) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic.
    Kennedy MH; Bertocchi I; Hopkins AD; Meredith SE
    Ann Trop Med Parasitol; 2002 Apr; 96(3):297-307. PubMed ID: 12061976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa.
    Murdoch ME; Asuzu MC; Hagan M; Makunde WH; Ngoumou P; Ogbuagu KF; Okello D; Ozoh G; Remme J
    Ann Trop Med Parasitol; 2002 Apr; 96(3):283-96. PubMed ID: 12061975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A community trial of ivermectin for onchocerciasis in Sierra Leone: clinical and parasitological responses to four doses given at six-monthly intervals.
    Whitworth JA; Morgan D; Maude GH; Luty AJ; Taylor DW
    Trans R Soc Trop Med Hyg; 1992; 86(3):277-80. PubMed ID: 1412652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Field-Based Evidence of Single and Few Doses of Annual Ivermectin Treatment Efficacy in Eliminating Skin Microfilaria Load after a Decade of Intervention.
    Osue HO
    Ethiop J Health Sci; 2017 Mar; 27(2):129-138. PubMed ID: 28579708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects.
    Albiez EJ; Newland HS; White AT; Kaiser A; Greene BM; Taylor HR; Büttner DW
    Trop Med Parasitol; 1988 Mar; 39(1):19-24. PubMed ID: 3291074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico.
    Rodriguez-Perez MA; Rodriguez MH; Margeli-Perez HM; Rivas-Alcala AR
    Am J Trop Med Hyg; 1995 May; 52(5):429-34. PubMed ID: 7771609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of community compliance with annual ivermectin treatment of onchocerciasis in Patigi, Nigeria.
    Oyibo WA; Fagbenro-Beyiku AF
    East Afr Med J; 1998 Apr; 75(4):237-42. PubMed ID: 9745842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemotherapy of onchocerciasis XX: ivermectin in combination with albendazole.
    Awadzi K; Addy ET; Opoku NO; Plenge-Bönig A; Büttner DW
    Trop Med Parasitol; 1995 Dec; 46(4):213-20. PubMed ID: 8826100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.